Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	18.66	21.66	16.35	11.94	130.98	10.2
Short-Term Investments	48.53	53.17	88.92	128.88	0	0
Cash & Cash Equivalents	67.19	74.82	105.27	140.82	130.98	10.2
Cash Growth	-30.71%	-28.92%	-25.25%	7.51%	1184.72%	-10.98%
Receivables	0.39	0.29	0.77	0.54	0.32	-0.77
Other Current Assets	2.41	2.3	5.25	4.77	2.06	1.93
Total Current Assets	69.99	77.41	111.28	146.13	133.36	11.35
Property, Plant & Equipment	2.77	2.95	3.52	3.18	0.97	1.58
Other Long-Term Assets	1.28	1.28	1.39	0.24	0.4	0.16
Total Long-Term Assets	4.05	4.23	4.91	3.42	1.37	1.73
Total Assets	74.04	81.64	116.19	149.54	134.73	13.09
Accounts Payable	5.19	1.97	1.96	1.44	1.37	0.66
Current Debt	0.7	0.69	0.68	0.55	0.86	0.87
Other Current Liabilities	5.96	7.78	5.18	4.57	3.89	3.26
Total Current Liabilities	11.84	10.44	7.81	6.56	6.12	4.78
Long-Term Debt	1.3	1.46	2.04	2.57	0.01	0.86
Other Long-Term Liabilities	0	0	0	0	0.44	0.13
Total Long-Term Liabilities	1.3	1.46	2.04	2.57	0.45	0.99
Total Liabilities	13.14	11.9	9.85	9.13	6.57	5.78
Total Debt	2	2.15	2.72	3.12	0.87	1.73
Debt Growth	-22.51%	-20.85%	-12.95%	258.92%	-49.66%	-
Retained Earnings	-348.76	-339.54	-298.1	-259.81	-231.5	-208.9
Comprehensive Income	-0.13	-0.07	-0.4	-0.14	0	0
Shareholders' Equity	60.89	69.74	106.34	140.42	128.16	7.31
Net Cash / Debt	65.19	72.67	102.55	137.7	130.11	8.47
Net Cash / Debt Growth	-30.94%	-29.13%	-25.53%	5.83%	1436.34%	-26.06%
Net Cash Per Share	1.46	1.63	2.35	3.53	6.23	1.42
Working Capital	58.15	66.97	103.48	139.57	127.24	6.57
Book Value Per Share	1.36	1.56	2.44	3.60	6.14	1.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).